Biotech

All Articles

Former Seagen CEO reveals new startup Ottimo Pharma

.After antibody-drug conjugate (ADC) specialist Seagen was offered to Pfizer in 2013 for an immense ...

Ironwood makes further bid for $1B GI medication along with new subgroup information

.On the heels of a phase 3 gain that fell short to impress capitalists, Ironwood Pharmaceuticals is ...

Novartis inks $150M bargain for autoimmune molecular adhesive

.Do not quit Monte Rosa Rehabs right now. The Boston-based biotech is actually having a ball after a...

Jade takes director team along with Chinook veterinarians-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our roundup of considerable management hirings, shootings a...

Septerna goes public with upsized offering of $288M

.Celebrating his firm's upsized going public (IPO), Septerna chief executive officer Jeffrey Finer s...

AbbVie makes Richter richer, paying out $25M to create finding contract

.AbbVie has actually gone back to the resource of its own antipsychotic giant Vraylar searching for ...

GenSight gets in last full weeks of money path as income flow edges out of reach

.GenSight Biologics is full weeks far from lacking cash. Once more. The biotech simply has enough mo...

AZ licenses thrown away uncommon health condition drug to Monopar Rehabs

.Monopar Therapies is actually recuperating a medication coming from the scrap heap of AstraZeneca's...

Arcus' brand-new HIF-2a data in renal cancer cells mean possible upper hand over Merck's Welireg, professionals mention

.Along with new data out on Arcus Biosciences' experimental HIF-2a inhibitor, one group of analysts ...

Roche bets as much as $1B to increase Dyno genetics therapy distribution contract

.After forming a gene therapy collaboration with Dyno Therapeutics in 2020, Roche is actually back f...